Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Epilepsy, Rolandic | 9 | 2024 | 57 | 6.540 |
Why?
|
Electroencephalography | 59 | 2024 | 6314 | 4.280 |
Why?
|
Seizures | 37 | 2024 | 2998 | 2.930 |
Why?
|
Epilepsy | 32 | 2024 | 3327 | 2.930 |
Why?
|
Thalamus | 6 | 2024 | 1047 | 1.890 |
Why?
|
Sleep Stages | 5 | 2024 | 706 | 1.740 |
Why?
|
Epilepsy, Generalized | 3 | 2024 | 181 | 1.570 |
Why?
|
Epilepsies, Partial | 4 | 2024 | 435 | 1.090 |
Why?
|
Brain Waves | 5 | 2024 | 417 | 1.060 |
Why?
|
Cerebral Cortex | 11 | 2024 | 5812 | 1.000 |
Why?
|
Sleep | 9 | 2024 | 4819 | 1.000 |
Why?
|
Epilepsia Partialis Continua | 1 | 2024 | 25 | 0.960 |
Why?
|
Tuberous Sclerosis | 7 | 2020 | 1042 | 0.940 |
Why?
|
Action Potentials | 3 | 2024 | 1838 | 0.930 |
Why?
|
Scalp | 4 | 2021 | 391 | 0.910 |
Why?
|
Nerve Net | 7 | 2021 | 2352 | 0.860 |
Why?
|
Models, Neurological | 6 | 2024 | 1776 | 0.860 |
Why?
|
Occipital Lobe | 2 | 2023 | 376 | 0.840 |
Why?
|
Anticonvulsants | 14 | 2021 | 1923 | 0.840 |
Why?
|
Brain Mapping | 9 | 2021 | 6685 | 0.830 |
Why?
|
Spasms, Infantile | 7 | 2022 | 301 | 0.810 |
Why?
|
Brain | 26 | 2024 | 27360 | 0.800 |
Why?
|
Angelman Syndrome | 2 | 2021 | 139 | 0.770 |
Why?
|
Delta Rhythm | 2 | 2021 | 81 | 0.750 |
Why?
|
Neural Pathways | 6 | 2022 | 3117 | 0.670 |
Why?
|
Cerebral Palsy | 1 | 2024 | 480 | 0.670 |
Why?
|
Infant, Newborn, Diseases | 6 | 2023 | 587 | 0.660 |
Why?
|
Child | 40 | 2024 | 80917 | 0.660 |
Why?
|
Malformations of Cortical Development | 1 | 2018 | 176 | 0.510 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2021 | 1140 | 0.510 |
Why?
|
Gangliosidosis, GM1 | 1 | 2014 | 11 | 0.480 |
Why?
|
Adolescent | 28 | 2024 | 89169 | 0.470 |
Why?
|
Chromosome Aberrations | 1 | 2021 | 1778 | 0.470 |
Why?
|
Pigmentation Disorders | 1 | 2014 | 105 | 0.450 |
Why?
|
Muscle Hypotonia | 1 | 2014 | 166 | 0.420 |
Why?
|
Infant | 27 | 2024 | 36535 | 0.420 |
Why?
|
Hypoxia-Ischemia, Brain | 3 | 2023 | 359 | 0.420 |
Why?
|
Child, Preschool | 28 | 2024 | 42669 | 0.410 |
Why?
|
Humans | 103 | 2024 | 768166 | 0.410 |
Why?
|
Infant, Newborn | 27 | 2024 | 26422 | 0.400 |
Why?
|
Sp4 Transcription Factor | 1 | 2011 | 2 | 0.390 |
Why?
|
Melanocytes | 1 | 2014 | 509 | 0.370 |
Why?
|
Sp1 Transcription Factor | 1 | 2011 | 143 | 0.360 |
Why?
|
Cognition | 3 | 2023 | 7073 | 0.340 |
Why?
|
Female | 63 | 2024 | 397192 | 0.340 |
Why?
|
Male | 63 | 2024 | 364719 | 0.330 |
Why?
|
TRPV Cation Channels | 1 | 2011 | 244 | 0.330 |
Why?
|
Drugs, Investigational | 1 | 2010 | 211 | 0.310 |
Why?
|
Computer Simulation | 4 | 2016 | 6283 | 0.300 |
Why?
|
Consciousness | 3 | 2022 | 602 | 0.300 |
Why?
|
Parents | 4 | 2024 | 3595 | 0.290 |
Why?
|
Predictive Value of Tests | 5 | 2024 | 15454 | 0.290 |
Why?
|
Sensory Receptor Cells | 1 | 2011 | 508 | 0.270 |
Why?
|
Prospective Studies | 22 | 2024 | 54926 | 0.250 |
Why?
|
Neurons | 2 | 2024 | 9514 | 0.250 |
Why?
|
Diffusion Tensor Imaging | 3 | 2023 | 2420 | 0.250 |
Why?
|
Young Adult | 16 | 2024 | 60066 | 0.230 |
Why?
|
Neurophysiology | 1 | 2024 | 145 | 0.220 |
Why?
|
Phenobarbital | 3 | 2021 | 192 | 0.220 |
Why?
|
Cysts | 1 | 2009 | 685 | 0.220 |
Why?
|
Magnetic Resonance Imaging | 15 | 2024 | 36743 | 0.210 |
Why?
|
Electrooculography | 2 | 2013 | 113 | 0.210 |
Why?
|
Stochastic Processes | 1 | 2024 | 360 | 0.210 |
Why?
|
Vigabatrin | 3 | 2022 | 88 | 0.210 |
Why?
|
Diazepam | 1 | 2023 | 214 | 0.200 |
Why?
|
Neurosurgical Procedures | 2 | 2024 | 2076 | 0.190 |
Why?
|
Status Epilepticus | 2 | 2020 | 463 | 0.190 |
Why?
|
Segmental Duplications, Genomic | 1 | 2021 | 20 | 0.190 |
Why?
|
Caregivers | 3 | 2024 | 2302 | 0.180 |
Why?
|
Genomic Structural Variation | 1 | 2021 | 80 | 0.180 |
Why?
|
Encephalitis, Herpes Simplex | 1 | 2021 | 65 | 0.180 |
Why?
|
Electrodes | 2 | 2021 | 617 | 0.180 |
Why?
|
Professional-Family Relations | 2 | 2021 | 501 | 0.170 |
Why?
|
Microelectrodes | 1 | 2021 | 305 | 0.170 |
Why?
|
Signal Processing, Computer-Assisted | 2 | 2020 | 1489 | 0.170 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2021 | 350 | 0.170 |
Why?
|
Anisotropy | 1 | 2023 | 1292 | 0.170 |
Why?
|
Algorithms | 3 | 2023 | 14164 | 0.160 |
Why?
|
Magnetoencephalography | 1 | 2023 | 641 | 0.160 |
Why?
|
Tumor Suppressor Proteins | 1 | 2009 | 2810 | 0.160 |
Why?
|
Monitoring, Physiologic | 4 | 2024 | 1798 | 0.160 |
Why?
|
Williams Syndrome | 1 | 2021 | 195 | 0.160 |
Why?
|
Electric Stimulation Therapy | 1 | 2024 | 635 | 0.150 |
Why?
|
Periventricular Nodular Heterotopia | 2 | 2016 | 57 | 0.150 |
Why?
|
Health Communication | 1 | 2021 | 216 | 0.150 |
Why?
|
Craniofacial Abnormalities | 1 | 2021 | 320 | 0.150 |
Why?
|
Registries | 7 | 2024 | 8375 | 0.150 |
Why?
|
Critical Care | 3 | 2024 | 2715 | 0.150 |
Why?
|
Chromosome Disorders | 1 | 2021 | 498 | 0.150 |
Why?
|
Adult | 22 | 2024 | 223646 | 0.150 |
Why?
|
Adrenocorticotropic Hormone | 2 | 2017 | 619 | 0.140 |
Why?
|
Somatosensory Cortex | 1 | 2000 | 516 | 0.140 |
Why?
|
Child Health Services | 1 | 2022 | 645 | 0.130 |
Why?
|
Motor Cortex | 2 | 2000 | 1013 | 0.130 |
Why?
|
Electric Stimulation | 1 | 2021 | 1741 | 0.130 |
Why?
|
Language | 2 | 2023 | 1557 | 0.130 |
Why?
|
Transcranial Magnetic Stimulation | 2 | 2016 | 1490 | 0.130 |
Why?
|
Intracranial Hemorrhages | 2 | 2021 | 810 | 0.130 |
Why?
|
Adaptation, Psychological | 2 | 2020 | 2663 | 0.130 |
Why?
|
Wakefulness | 1 | 2022 | 1284 | 0.120 |
Why?
|
Family Health | 1 | 2020 | 1255 | 0.120 |
Why?
|
Hyperlipoproteinemia Type III | 1 | 2014 | 3 | 0.120 |
Why?
|
Neuronal Plasticity | 2 | 2000 | 1448 | 0.120 |
Why?
|
Evoked Potentials | 1 | 2021 | 1058 | 0.120 |
Why?
|
Persistent Vegetative State | 1 | 2017 | 274 | 0.120 |
Why?
|
Alpha Rhythm | 1 | 2015 | 112 | 0.120 |
Why?
|
Anesthetics | 1 | 2020 | 525 | 0.120 |
Why?
|
Infectious Disease Incubation Period | 1 | 2014 | 16 | 0.110 |
Why?
|
Analysis of Variance | 2 | 2013 | 6229 | 0.110 |
Why?
|
Multidrug Resistance-Associated Proteins | 1 | 2014 | 105 | 0.110 |
Why?
|
Developmental Disabilities | 2 | 2021 | 1518 | 0.110 |
Why?
|
Rabies | 1 | 2014 | 56 | 0.110 |
Why?
|
Fourier Analysis | 1 | 2014 | 439 | 0.110 |
Why?
|
Gene Expression Regulation | 1 | 2011 | 11928 | 0.110 |
Why?
|
Pharmaceutical Preparations | 1 | 2021 | 1088 | 0.100 |
Why?
|
Disabled Persons | 1 | 2022 | 1210 | 0.100 |
Why?
|
Middle Aged | 12 | 2024 | 223492 | 0.100 |
Why?
|
Lipase | 1 | 2014 | 321 | 0.100 |
Why?
|
Infant, Premature | 3 | 2017 | 2124 | 0.100 |
Why?
|
Early Diagnosis | 1 | 2017 | 1194 | 0.100 |
Why?
|
Societies, Medical | 1 | 2024 | 3968 | 0.100 |
Why?
|
Case-Control Studies | 4 | 2024 | 22291 | 0.100 |
Why?
|
Numerical Analysis, Computer-Assisted | 1 | 2012 | 119 | 0.100 |
Why?
|
Preoperative Care | 1 | 2021 | 2258 | 0.100 |
Why?
|
Ectodermal Dysplasia | 1 | 2012 | 107 | 0.100 |
Why?
|
Forecasting | 1 | 2021 | 2945 | 0.100 |
Why?
|
Sp3 Transcription Factor | 1 | 2011 | 30 | 0.100 |
Why?
|
Fraser Syndrome | 1 | 2011 | 5 | 0.100 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2021 | 1901 | 0.100 |
Why?
|
Hypertelorism | 1 | 2011 | 29 | 0.090 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2023 | 2815 | 0.090 |
Why?
|
PC12 Cells | 1 | 2011 | 317 | 0.090 |
Why?
|
Likelihood Functions | 1 | 2014 | 994 | 0.090 |
Why?
|
Anus, Imperforate | 1 | 2011 | 63 | 0.090 |
Why?
|
Coloboma | 1 | 2011 | 60 | 0.090 |
Why?
|
Infant, Premature, Diseases | 1 | 2016 | 712 | 0.090 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 2012 | 423 | 0.090 |
Why?
|
Nerve Growth Factor | 1 | 2011 | 156 | 0.090 |
Why?
|
Receptors, Interleukin | 1 | 2011 | 243 | 0.080 |
Why?
|
Risk Factors | 7 | 2021 | 74944 | 0.080 |
Why?
|
Cohort Studies | 11 | 2022 | 41754 | 0.080 |
Why?
|
Neuronal Ceroid-Lipofuscinoses | 1 | 2010 | 134 | 0.080 |
Why?
|
Apolipoproteins E | 1 | 2014 | 1461 | 0.080 |
Why?
|
Longevity | 2 | 2023 | 1077 | 0.080 |
Why?
|
Ganglia, Spinal | 1 | 2011 | 529 | 0.080 |
Why?
|
Follow-Up Studies | 5 | 2019 | 39348 | 0.080 |
Why?
|
Anxiety | 2 | 2020 | 4672 | 0.080 |
Why?
|
Guideline Adherence | 1 | 2018 | 2235 | 0.070 |
Why?
|
Age of Onset | 4 | 2018 | 3347 | 0.070 |
Why?
|
Age Factors | 3 | 2021 | 18412 | 0.070 |
Why?
|
Emigrants and Immigrants | 1 | 2014 | 550 | 0.070 |
Why?
|
Hamartoma | 1 | 2009 | 236 | 0.070 |
Why?
|
Motor Skills | 2 | 2000 | 523 | 0.070 |
Why?
|
Uncertainty | 2 | 2023 | 769 | 0.070 |
Why?
|
Adrenal Cortex Hormones | 1 | 2016 | 1886 | 0.070 |
Why?
|
Extracellular Matrix Proteins | 1 | 2011 | 832 | 0.070 |
Why?
|
Gene Knockdown Techniques | 1 | 2011 | 1606 | 0.070 |
Why?
|
Withholding Treatment | 2 | 2021 | 620 | 0.070 |
Why?
|
Animals | 9 | 2024 | 169246 | 0.070 |
Why?
|
Reference Values | 1 | 2013 | 4938 | 0.070 |
Why?
|
Phylogeny | 1 | 2014 | 2843 | 0.070 |
Why?
|
Autistic Disorder | 1 | 2015 | 1240 | 0.060 |
Why?
|
Software | 1 | 2020 | 4478 | 0.060 |
Why?
|
Photic Stimulation | 1 | 2012 | 1997 | 0.060 |
Why?
|
Retrospective Studies | 10 | 2024 | 81762 | 0.060 |
Why?
|
Body Height | 1 | 2011 | 1565 | 0.060 |
Why?
|
Stress, Psychological | 1 | 2020 | 4530 | 0.060 |
Why?
|
Intralaminar Thalamic Nuclei | 1 | 2024 | 17 | 0.060 |
Why?
|
Epilepsy, Tonic-Clonic | 1 | 2024 | 54 | 0.060 |
Why?
|
Longitudinal Studies | 3 | 2024 | 14783 | 0.060 |
Why?
|
Genetic Testing | 1 | 2017 | 3591 | 0.060 |
Why?
|
Heart Defects, Congenital | 1 | 2021 | 4712 | 0.060 |
Why?
|
Delivery of Health Care | 1 | 2022 | 5367 | 0.060 |
Why?
|
Premature Birth | 1 | 2016 | 1829 | 0.060 |
Why?
|
Forelimb | 2 | 2000 | 116 | 0.050 |
Why?
|
Abnormalities, Multiple | 1 | 2011 | 1424 | 0.050 |
Why?
|
Mutation, Missense | 1 | 2012 | 2592 | 0.050 |
Why?
|
Phase Transition | 1 | 2023 | 70 | 0.050 |
Why?
|
Rats, Long-Evans | 2 | 2000 | 380 | 0.050 |
Why?
|
United States | 9 | 2024 | 73039 | 0.050 |
Why?
|
Entropy | 1 | 2022 | 211 | 0.050 |
Why?
|
Intensive Care, Neonatal | 1 | 2024 | 200 | 0.050 |
Why?
|
Circadian Rhythm | 1 | 2013 | 2593 | 0.050 |
Why?
|
RNA, Small Interfering | 1 | 2011 | 3428 | 0.050 |
Why?
|
Frameshift Mutation | 2 | 2014 | 392 | 0.050 |
Why?
|
Neonatology | 1 | 2024 | 141 | 0.050 |
Why?
|
Quality of Life | 2 | 2020 | 13490 | 0.050 |
Why?
|
Rats | 3 | 2011 | 23760 | 0.050 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2009 | 1942 | 0.050 |
Why?
|
Alzheimer Disease | 1 | 2023 | 8759 | 0.050 |
Why?
|
Chromosome Breakpoints | 1 | 2021 | 93 | 0.050 |
Why?
|
Intensive Care Units | 1 | 2014 | 3800 | 0.050 |
Why?
|
Rehabilitation | 1 | 2022 | 129 | 0.050 |
Why?
|
Implantable Neurostimulators | 1 | 2021 | 75 | 0.040 |
Why?
|
Body Weight | 1 | 2011 | 4627 | 0.040 |
Why?
|
Depression | 1 | 2020 | 8230 | 0.040 |
Why?
|
Brain Diseases | 1 | 2009 | 1554 | 0.040 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2014 | 9015 | 0.040 |
Why?
|
Neoplasms | 1 | 2009 | 22371 | 0.040 |
Why?
|
Promoter Regions, Genetic | 1 | 2011 | 5797 | 0.040 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2021 | 361 | 0.040 |
Why?
|
Qualitative Research | 2 | 2021 | 3140 | 0.040 |
Why?
|
Chromosomes, Human, Pair 16 | 1 | 2021 | 341 | 0.040 |
Why?
|
Nuclear Family | 1 | 2020 | 311 | 0.040 |
Why?
|
Protein Binding | 1 | 2011 | 9343 | 0.040 |
Why?
|
Virus Activation | 1 | 2021 | 324 | 0.040 |
Why?
|
Hindlimb | 1 | 2000 | 516 | 0.040 |
Why?
|
Gestational Age | 2 | 2018 | 3621 | 0.040 |
Why?
|
Models, Biological | 2 | 2012 | 9495 | 0.040 |
Why?
|
Dendrites | 1 | 2000 | 472 | 0.040 |
Why?
|
KCNQ3 Potassium Channel | 1 | 2017 | 10 | 0.040 |
Why?
|
KCNQ2 Potassium Channel | 1 | 2017 | 19 | 0.040 |
Why?
|
Aged | 5 | 2021 | 171504 | 0.040 |
Why?
|
Cognition Disorders | 1 | 2011 | 3980 | 0.040 |
Why?
|
Patient Discharge | 2 | 2021 | 3479 | 0.040 |
Why?
|
Glasgow Outcome Scale | 1 | 2017 | 101 | 0.040 |
Why?
|
Risk Assessment | 1 | 2019 | 24315 | 0.040 |
Why?
|
Object Attachment | 1 | 2020 | 326 | 0.040 |
Why?
|
Prednisolone | 1 | 2017 | 326 | 0.030 |
Why?
|
Reproducibility of Results | 3 | 2021 | 20227 | 0.030 |
Why?
|
Treatment Outcome | 5 | 2024 | 65371 | 0.030 |
Why?
|
Imagination | 1 | 2017 | 226 | 0.030 |
Why?
|
RNA, Messenger | 1 | 2011 | 12800 | 0.030 |
Why?
|
Chromosome Deletion | 1 | 2021 | 1385 | 0.030 |
Why?
|
Hypothermia, Induced | 1 | 2021 | 754 | 0.030 |
Why?
|
Deep Brain Stimulation | 1 | 2024 | 851 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2021 | 1443 | 0.030 |
Why?
|
Glasgow Coma Scale | 1 | 2017 | 574 | 0.030 |
Why?
|
Infant Mortality | 1 | 2020 | 752 | 0.030 |
Why?
|
Herpesvirus 1, Human | 1 | 2021 | 743 | 0.030 |
Why?
|
Communicable Disease Control | 1 | 2022 | 857 | 0.030 |
Why?
|
Multivariate Analysis | 2 | 2019 | 12077 | 0.030 |
Why?
|
High-Density Lipoproteins, Pre-beta | 1 | 2014 | 6 | 0.030 |
Why?
|
Xanthomatosis | 1 | 2014 | 32 | 0.030 |
Why?
|
Apolipoproteins C | 1 | 2014 | 59 | 0.030 |
Why?
|
Music | 1 | 2017 | 247 | 0.030 |
Why?
|
Patient Selection | 2 | 2021 | 4260 | 0.030 |
Why?
|
Insulin | 1 | 2009 | 6607 | 0.030 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2021 | 862 | 0.030 |
Why?
|
Apolipoproteins A | 1 | 2014 | 96 | 0.030 |
Why?
|
Synapses | 2 | 2000 | 1765 | 0.030 |
Why?
|
Pregnancy | 1 | 2016 | 30256 | 0.030 |
Why?
|
Parenting | 1 | 2020 | 708 | 0.030 |
Why?
|
Health Care Surveys | 1 | 2021 | 2434 | 0.030 |
Why?
|
Functional Laterality | 1 | 2000 | 2264 | 0.030 |
Why?
|
Lipoproteins, VLDL | 1 | 2014 | 201 | 0.030 |
Why?
|
Observer Variation | 1 | 2020 | 2622 | 0.030 |
Why?
|
Hospice Care | 1 | 2020 | 678 | 0.030 |
Why?
|
Drug Resistance | 1 | 2019 | 1599 | 0.030 |
Why?
|
Membrane Proteins | 1 | 2010 | 7876 | 0.030 |
Why?
|
Behavior, Animal | 1 | 2000 | 1862 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2020 | 14729 | 0.030 |
Why?
|
Psychomotor Performance | 1 | 2000 | 1892 | 0.020 |
Why?
|
Disease Progression | 1 | 2009 | 13671 | 0.020 |
Why?
|
Brain Injuries | 2 | 2000 | 2057 | 0.020 |
Why?
|
Biophysics | 1 | 2012 | 379 | 0.020 |
Why?
|
3-Hydroxybutyric Acid | 1 | 2011 | 72 | 0.020 |
Why?
|
Lipoproteins, LDL | 1 | 2014 | 644 | 0.020 |
Why?
|
Sequence Analysis, DNA | 2 | 2014 | 4786 | 0.020 |
Why?
|
Fear | 1 | 2020 | 1495 | 0.020 |
Why?
|
COS Cells | 1 | 2012 | 1135 | 0.020 |
Why?
|
Mutation | 3 | 2011 | 30238 | 0.020 |
Why?
|
Nose Diseases | 1 | 2011 | 78 | 0.020 |
Why?
|
Intelligence Tests | 1 | 2011 | 504 | 0.020 |
Why?
|
Microsatellite Repeats | 1 | 2012 | 785 | 0.020 |
Why?
|
Learning | 1 | 1999 | 1759 | 0.020 |
Why?
|
Lipoproteins, HDL | 1 | 2014 | 682 | 0.020 |
Why?
|
Hernia, Umbilical | 1 | 2011 | 102 | 0.020 |
Why?
|
Brazil | 1 | 2014 | 1250 | 0.020 |
Why?
|
Cause of Death | 1 | 2020 | 3721 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2009 | 16045 | 0.020 |
Why?
|
Acute Disease | 1 | 2020 | 7243 | 0.020 |
Why?
|
Prognosis | 2 | 2020 | 30010 | 0.020 |
Why?
|
Dogs | 1 | 2014 | 3845 | 0.020 |
Why?
|
Patient Care Team | 1 | 2020 | 2523 | 0.020 |
Why?
|
Eyelids | 1 | 2011 | 278 | 0.020 |
Why?
|
Finland | 1 | 2010 | 609 | 0.020 |
Why?
|
Drug Prescriptions | 1 | 2018 | 1668 | 0.020 |
Why?
|
Prevalence | 2 | 2016 | 15869 | 0.020 |
Why?
|
Anal Canal | 1 | 2011 | 376 | 0.020 |
Why?
|
Carotid Artery Diseases | 1 | 2014 | 879 | 0.020 |
Why?
|
Odds Ratio | 1 | 2020 | 9669 | 0.020 |
Why?
|
Hospitals, Pediatric | 1 | 2017 | 1876 | 0.020 |
Why?
|
Administration, Oral | 1 | 2016 | 4030 | 0.020 |
Why?
|
Neuropsychological Tests | 2 | 2011 | 7140 | 0.020 |
Why?
|
Genotype | 2 | 2014 | 13045 | 0.020 |
Why?
|
Nose | 1 | 2011 | 522 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2017 | 6316 | 0.020 |
Why?
|
Triglycerides | 1 | 2014 | 2464 | 0.020 |
Why?
|
Gene Dosage | 1 | 2011 | 1219 | 0.020 |
Why?
|
Exercise Test | 1 | 2014 | 2186 | 0.020 |
Why?
|
Intelligence | 1 | 2011 | 926 | 0.020 |
Why?
|
Anthropometry | 1 | 2011 | 1346 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2014 | 1904 | 0.020 |
Why?
|
Skin Diseases | 1 | 2014 | 1085 | 0.020 |
Why?
|
Signal Transduction | 1 | 2009 | 23645 | 0.020 |
Why?
|
Logistic Models | 1 | 2020 | 13290 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2020 | 59629 | 0.020 |
Why?
|
Phenotype | 2 | 2014 | 16726 | 0.010 |
Why?
|
Syndrome | 1 | 2011 | 3272 | 0.010 |
Why?
|
Telemedicine | 1 | 2022 | 3109 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2012 | 4120 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 4580 | 0.010 |
Why?
|
Sex Factors | 1 | 2017 | 10632 | 0.010 |
Why?
|
Retina | 1 | 2014 | 2662 | 0.010 |
Why?
|
Time Factors | 2 | 2016 | 40218 | 0.010 |
Why?
|
Pedigree | 1 | 2011 | 4539 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2009 | 3436 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2012 | 2744 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2011 | 3800 | 0.010 |
Why?
|
Length of Stay | 1 | 2016 | 6498 | 0.010 |
Why?
|
Forkhead Transcription Factors | 1 | 2009 | 1625 | 0.010 |
Why?
|
Critical Illness | 1 | 2014 | 2756 | 0.010 |
Why?
|
Ultrasonography | 1 | 2014 | 6004 | 0.010 |
Why?
|
Mental Disorders | 1 | 2021 | 6874 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2009 | 2457 | 0.010 |
Why?
|
Base Sequence | 1 | 2011 | 12421 | 0.010 |
Why?
|
Osteoporosis | 1 | 2009 | 1605 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2010 | 4249 | 0.010 |
Why?
|
Electrocardiography | 1 | 2012 | 6412 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2011 | 17622 | 0.010 |
Why?
|
Blood Glucose | 1 | 2011 | 6430 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2014 | 15948 | 0.010 |
Why?
|
Genome, Human | 1 | 2009 | 4446 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2017 | 18065 | 0.010 |
Why?
|
Mice | 2 | 2012 | 82029 | 0.010 |
Why?
|
Axons | 1 | 1999 | 1677 | 0.010 |
Why?
|
Motor Activity | 1 | 1999 | 2711 | 0.010 |
Why?
|